Compugen (CGEN) Current Leases (2019 - 2026)
Compugen (CGEN) posted quarterly Current Leases of $559000.0 for Q1 2026, up 32.15% year-over-year from $423000.0 in Q1 2025, and up 7.29% on a QoQ basis from $521000.0 in Q4 2025.
Powered by 
Analysis
Compugen (CGEN) Current Leases (2019 - 2026) Analysis & Trends
Compugen has reported Current Leases for 8 years, with the latest figure at $559000.0 in Q1 2026.
- Current Leases for Q1 2026 came in at $559000.0, up 32.15% year-over-year; the trailing twelve-month figure through Mar 2026 was $559000.0 (up 32.15% YoY), and the FY2025 annual result was $521000.0, up 16.29% from the prior year.
- Current Leases improved to $559000.0 in Q1 2026, from $521000.0 in the prior quarter.
- Over five years, Current Leases peaked at $764000.0 in Q1 2022 and troughed at $423000.0 in Q1 2025.
- A 5-year average of $546058.8 and a median of $559000.0 in 2026 frame the typical range for Current Leases.
- The widest annual swing landed in 2024, when Current Leases decreased 29.11%; it then surged 32.15% in 2026.
- A 5-year view of Current Leases shows it stood at $613000.0 in 2022, then grew by 3.1% to $632000.0 in 2023, then decreased by 29.11% to $448000.0 in 2024, then grew by 16.29% to $521000.0 in 2025, then grew by 7.29% to $559000.0 in 2026.
- Per Business Quant data, the three most recent Current Leases figures were $559000.0 in Q1 2026, $521000.0 in Q4 2025, and $486000.0 in Q3 2025.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Current Leases (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 138.47 Bn | 130.62 Bn | 2.84 Bn | - |
| 2 | Regeneron Pharmaceuticals | 85.18 Bn | 77.19 Bn | 3.93 Bn | 720.00 Mn |
| 3 | Argenx Se | 63.38 Bn | 58.19 Bn | 1.37 Bn | 11.00 Mn |
| 4 | Moderna | 58.09 Bn | 52.95 Bn | 52.00 Mn | - |
| 5 | Revolution Medicines | 44.33 Bn | 44.33 Bn | - | 16.75 Mn |
| 6 | BeOne Medicines | 40.02 Bn | 34.92 Bn | 1.53 Bn | 21.95 Mn |
| 7 | Alnylam Pharmaceuticals | 35.57 Bn | 32.27 Bn | 992.69 Mn | 45.93 Mn |
| 8 | Royalty Pharma | 28.45 Bn | 27.61 Bn | - | - |
| 9 | Insmed | 27.48 Bn | 26.32 Bn | 358.27 Mn | 6.27 Mn |
| 10 | Compugen | 242.44 Mn | 156.82 Mn | -92,000.00 | 623,000.00 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 623,000.00 |
| Mar 31, 2026 | 559,000.00 |
| Dec 31, 2025 | 521,000.00 |
| Sep 30, 2025 | 486,000.00 |
| Jun 30, 2025 | 471,000.00 |
| Mar 31, 2025 | 423,000.00 |
| Dec 31, 2024 | 448,000.00 |
| Sep 30, 2024 | 447,000.00 |
| Jun 30, 2024 | 449,000.00 |
| Mar 31, 2024 | 441,000.00 |
| Dec 31, 2023 | 632,000.00 |
| Sep 30, 2023 | 592,000.00 |
| Jun 30, 2023 | 610,000.00 |
| Mar 31, 2023 | 617,000.00 |
| Dec 31, 2022 | 613,000.00 |
| Sep 30, 2022 | 595,000.00 |
| Jun 30, 2022 | 615,000.00 |
| Mar 31, 2022 | 764,000.00 |
| Dec 31, 2021 | 768,000.00 |
| Sep 30, 2021 | 760,000.00 |